Please provide your email address to receive an email when new articles are posted on . Consider angle morphology when treating patients with neovascular glaucoma. Comparable visual acuity and IOP and ...

Purpose: To investigate the rate and risk factors for neovascular glaucoma (NVG) after vitrectomy in proliferative diabetic retinopathy (PDR). Methods: Five hundred and twelve patients (512 eyes) with ...

Please provide your email address to receive an email when new articles are posted on . Older patients and women were more likely to progress to severe vision loss. Severe vision loss was less common ...

A novel gene therapy (ABBV-RGX-314) was well tolerated and reduced treatment burden in patients with bilateral neovascular age-related macular degeneration (AMD), according to results of a phase II ...

The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

Patients with retinal vein occlusion-related macular edema had a higher likelihood of blindness and low vision if they had low best-corrected visual acuity after 1 month of intravitreal treatment.

Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...